(CIDRAP News) The World Health Organization (WHO) said today that oseltamivir (Tamiflu)-resistant pandemic H1N1 cases in hospital settings suggest that treatment doses may need to be increased in immunocompromised patients who have flu symptoms.
The agency made this statement after a teleconference with experts about two recent clusters of resistant cases. It also concluded that the events don't signal a public health threat.
(CIDRAP News) A second seasonal influenza vaccine made by Novartis was approved recently by the US Food and Drug Administration (FDA), and the company said some doses may reach the market this flu season.
(CIDRAP News) Decreasing pandemic flu activity and growing supplies of vaccine offer a window of opportunity for people to protect themselves from the virus, especially if the nation experiences a third wave of infections, Thomas Frieden, MD, director of the US Centers for Disease Control and Prevention (CDC) said today.
(CIDRAP News) The number of states with widespread pandemic flu activity dropped for the third week in a row, but the virus continued to take a heavy toll on children, with at least 27 more pediatric deaths reported the week of Nov 15 to 21, the US Centers for Disease Control and Prevention (CDC) said today.